The brain plays a crucial role in regulating sleep and wakefulness. Several areas of the brain are involved in this process, including the hypothalamus, the brainstem, and the thalamus. These areas work together to control the transitions between sleep and wakefulness and to regulate sleep patterns.

In patients with superficial siderosis, the iron deposition can cause damage to these areas of the brain. This can disrupt the normal functioning of the sleep-wake cycle and lead to sleep disturbances. 

Possible Affected Areas

  1. Hypothalamus Damage: The hypothalamus contains clusters of nerve cells that act as control centers affecting sleep and arousal. Damage to these cells can disrupt the balance between sleep and wakefulness, leading to excessive sleepiness or difficulty staying awake.
  2. Brainstem Damage: The brainstem communicates with the hypothalamus to increase the production of the neurotransmitter GABA, which reduces arousal and promotes sleep. Damage to the brainstem can disrupt this process, leading to prolonged periods of sleep.
  3. Thalamus Damage: The thalamus is a relay station for information from the senses to the cerebral cortex. During most stages of sleep, the thalamus becomes quiet, letting you tune out the external world. Damage to the thalamus can disrupt this process, leading to altered sleep patterns.


In the later stages of superficial siderosis, the damage to these brain areas can become more severe. This can lead to a condition known as hypersomnia, where patients sleep excessively, often for extended periods of 16 to 20 hours a day. Additionally, these patients may find it challenging to stay awake, especially when they are still or not actively engaged in tasks. In the context of superficial siderosis, hypersomnia is considered a secondary condition because it arises due to the primary disease process – free-iron and oxidative stress and subsequent neurological damage.

It’s also worth noting that other factors, such as reduced physical activity, psychological stress, and other disease symptoms, can exacerbate the fatigue and excessive sleepiness seen in superficial siderosis patients. 

Steps to Help Manage This Fatigue

  1. Encourage Regular, Balanced Meals: Proper nutrition can help boost energy levels. Encourage the patient to eat regular, balanced meals rich in fruits, vegetables, lean proteins, and whole grains.
  2. Promote Physical Activity: While it’s essential to respect the patient’s limitations, encourage gentle physical activity, such as walking or stretching, as tolerated. This can help boost energy levels and improve mood.
  3. Ensure Adequate Hydration: Dehydration can exacerbate feelings of fatigue. Ensure the patient is drinking enough fluids throughout the day.
  4. Support Good Sleep Hygiene: Encourage regular sleep hours, a quiet and dark sleep environment, and avoid caffeine and electronics before bed.
  5. Manage Stress: Help the patient find ways to manage stress, such as through relaxation techniques, mindfulness, or talking to a mental health professional.
  6. Coordinate with Healthcare Providers: Work closely with the patient’s healthcare providers to manage symptoms, adjust medications as needed, and address any underlying conditions contributing to fatigue.

This general overview may not apply to all patients with superficial siderosis. Each patient’s experience with the disease can vary widely, and their care plan should be individualized based on their specific symptoms and needs.

UPDATED June 17, 2023

¹Innov Clin Neurosci. 2011 Oct; 8(10): 40–43. Published online 2011 Oct. PMCID: PMC3225130 PMID: 22132370
Fatigue as a Residual Symptom of Depression
Steven D. Targum, MD,
corresponding author, and Maurizio Fava, MD
Sources: Superficial siderosis is a rare neurologic disease characterized by progressive sensorineural hearing loss, cerebellar ataxia, pyramidal signs, and neuroimaging findings revealing hemosiderin deposits in the spinal and cranial leptomeninges and subpial layer. The disease progresses slowly, and patients may present with mild cognitive impairment, nystagmus, dysmetria, spasticity, dysdiadochokinesia, dysarthria, hyperreflexia, and Babinski signs. Additional features reported include dementia, urinary incontinence, anosmia, ageusia, and anisocoria. Superficial siderosis MedGen UID: 831707 •Concept ID: CN226971 •Finding Orphanet: ORPHA247245
Living With SuperficialSiderosis Website PubMed Reference Library 
Back to top button